Status:
COMPLETED
Prognostic Impact of Physical Activity Patterns After Percutaneous Coronary Intervention (PIPAP Study)
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Physical Activity
Coronary Artery Disease
Eligibility:
All Genders
18-79 years
Brief Summary
Physical activity monitoring after coronary bypass grafting and other major surgeries has been found to be predictive for hospital readmission and adverse outcome. In patients after percutaneous coron...
Detailed Description
Study design This is a monocentric open label explorative study (with primary objective to assess the predictive value of daily steps for MACE). Patients will be asked to wear an activity tracker for...
Eligibility Criteria
Inclusion
- Eligible for ambulatory cardiac rehabilitation (CR, patients not living in nursing home, not enrolling in stationary CR)
- Signing informed consent
Exclusion
- Staged PCI;
- Previous participation in this study;
- Inability or contraindications to undergo CR (nursing home residence, stationary CR, orthopedic or neurologic impairment prohibiting physical exercise, psychiatric conditions)
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc..
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
568 Patients enrolled
Trial Details
Trial ID
NCT04663373
Start Date
December 1 2020
End Date
November 1 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Preventive Cardiology, Bern University Hospital
Bern, Switzerland, 3010